Posts Tagged ‘ MAUDE ’

Q&A: Dr. Anthony Visco, AUGS President

Mar 31st, 2013 | By
Q&A: Dr. Anthony Visco, AUGS President

April 3, 2013 ~ Dr. Anthony Visco is Chief of Urogynecology at Duke Univ. Medical Center and President of AUGS.  The American Urogynecologic Society (AUGS) was founded in 1979 and is a professional organization of 1,400 physicians and allied health professionals who care for women with pelvic floor disorders, specifically pelvic organ prolapse (POP) and
[continue reading...]



Breaking News ~ J & J Sold Vaginal Mesh Implant Without FDA Approval

Mar 21st, 2012 | By
Breaking News ~ J & J Sold Vaginal Mesh Implant Without FDA Approval

March 21 ~ Bloomberg is reporting (here) that major medical device maker Johnson & Johnson (J&J) sold the Gynecare Prolift surgical mesh for three years before it was approved by the U.S. Food and Drug Administration (FDA). The mesh is now the subject of more than 550 lawsuits, reports Bloomberg. Prolift is a pre-cut mesh
[continue reading...]



To Whom Have You Reported Your ‘Adverse Event’ ?

Nov 14th, 2011 | By
To Whom Have You Reported Your  ‘Adverse Event’ ?

I have a question – Assuming you’ve had a problem with synthetic surgical mesh, who have you reported your complications to?   The manufacturer, the FDA?  Share this:



FDA Panel Wants More Data on Mesh Tx for Incontinence, MedPage Today, September 9

Sep 13th, 2011 | By

MedPage Today (here)  reports an FDA advisory panel meeting over synthetic mesh used to treat stress urinary incontinence (SUI) said it would like more scientific data on the newer generation of devices but recommended leaving in place the 510(k) approval process. FDA Panel Listens to Industry, Patients, Staff The Obstetrics and Gynecology Devices panel issued
[continue reading...]



We hope you find this a helpful resource. National News Editor, Jane Akre, began MDND with the hope of providing the latest news, information and perspective from the regulatory, industry and patient point of view, something that goes under-reported in much of the coverage of medical devices. The public is just now becoming aware that many devices do not undergo the same scrutiny as prescription drugs and are instead grandfathered in under an FDA loophole that has gone largely unchanged since the 1970s. As a result, patients become the post-market clinical trial subjects, and many suffer devastating and permanent injuries.